新的代谢预后得分用于预测癌症患者的生存率
Jinyu Shi1,2,3,4, Chenan Liu1,2,3,4, Xin Zheng1,2,3,4
1Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
Scientific reports
|January 8, 2025
概括
一个新的代谢预后系统识别了血红蛋白和白蛋白等关键指标,以评估癌症患者的代谢障碍负担. 较高的负担与较差的生存率相关,有助于预测预后.
科学领域:
- 在瘤学瘤学.
- 代谢障碍 代谢障碍 代谢障碍
- 预测 预测 预测 预测 预测
背景情况:
- 癌症是全球主要的死亡原因,通常与代谢障碍同时发生.
- 评估癌症患者的代谢障碍负担对于了解预后至关重要.
研究的目的:
- 为癌症患者开发一种新的代谢预后系统.
- 评估代谢障碍负担与患者存活率之间的关系.
主要方法:
- 利用了来自"常见癌症的营养状况和临床结果调查" (INSCOC) 项目的数据.
- 雇佣最低绝对收缩和选择操作员 (LASSO) 分析以确定代谢障碍指标.
- 应用了考克斯回归,卡普兰-梅尔分析,以及用于预后评估的诺姆图构造.
主要成果:
- 五种血液学指数 (血红蛋白,中性粒细胞,直接胆红素,白蛋白,球蛋白) 被确定为关键指标.
- 更高的代谢障碍负担与较差的患者存活率有显著的关联.
- 开发的诺米图表显示了1,3年和5年整体生存期的良好预测准确性 (AUC 0.678,0.664,0.650).
结论:
- 这种新的预后系统准确地评估了癌症患者的代谢障碍负担.
- 纳米图和计算器为预测癌症患者预后提供了宝贵的工具.
- 这些发现强调了代谢标记在瘤治疗中的临床实用性.
相关概念视频
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:24Kaplan-Meier Approach
90
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
90